Simple Therapies Boost Heart Attack Survival

Mukherjee believes the Swedish research could yield similar results in the U.S.

Mukherjee believes the Swedish research could yield similar results in the U.S.

According to research recently published in the Journal of the American Medical Association and an accompanying commentary by Debabrata Mukherjee, M.D., chief of cardiovascular medicine at the Paul L. Foster School of Medicine, the increased use of evidence-based treatments for heart attacks like rapid angioplasty has led to a decrease in deaths from heart attacks.

Cardiovascular disease remains the most common cause of morbidity and mortality in the U.S.

In the study, Thomas Jernberg of the Karolinska Institute in Stockholm and his colleagues used data from a Swedish registry on more than 61,000 patients who experienced a deadly heart attack known as STEMI between 1996 and 2007.

“The combined use of simple therapies such as aspirin and cholesterol-lowering medications and balloon stents were associated with a significant reduction in mortality,” Mukherjee said. “We would expect to have similar findings in the United States.”

Read the full story from Reuters >>


PAP Smears: What, Why and When

El Paso Doctors Improving Outcomes of Brain Injuries

Organ and Tissue Donation Offers a Second Chance at Life

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories


TTUHSC’s La-Beck to Use NIH Grant to Study Cancer Drug Delivery Via Nanoparticles

Ninh (Irene) La-Beck, Pharm.D., with the TTUHSC Jerry H. Hodge School of Pharmacy, received a five-year, $2.49 million grant to investigate how nanoparticles interact with the immune system and cancer.


TTUHSC’s Wilkerson to Investigate Links Between Pain and Basal Sex Hormone Levels

To help investigate the influence basal sex hormone alterations may have on chronic post-op pain, the NIH recently awarded a grant to Jenny Wilkerson, Ph.D., from the Jerry H. Hodge School of Pharmacy.


Tackling Heart Health for Athletes

Scott Shurmur, M.D., a cardiologist at the Texas Tech Physicians Center for Cardiovascular Health, shared his expertise and his experience as a former collegiate athlete.